Abstract
Human ovarian follicular fluid (HOFF) contains proteins, extracellular matrixes necessary for growth and maturation of oocytes as well as granulosa cells. Epithelial cells and stem cells can be isolated from HOFF. However, information regarding stem cells derived from HOFF is still lacking. The objectives of the present study were to isolate, characterize, and differentiate cells derived from HOFF. HOFF was collected during the routine aspiration of oocytes in an assisted fertilization program and subjected to cell isolation, characterization, and in vitro culture. After 24 h of culture, different cell morphologies including epithelial-like-, neural-like- and fibroblast-like cells were observed. Immunocytochemistry reveals the expression of pluripotent stem cell markers (OCT4, NANOG, SSEA4), epithelial marker (CK18), FSH- and LH-receptor. For in vitro culture, the isolated cells were continuously cultured in a growth medium; alpha MEM containing 10% FBS and epidermal growth factor (EGF). After 2 weeks of in vitro culture, cells with fibroblast-like morphology dominantly grow in the culture vessels and resemble mesenchymal stem cells (MSCs). HOFF-derived cells exhibited MSC expression of CD44, CD73, CD90, CD105, CD146, and STRO-1, and were capable of differentiation into osteoblasts, chondrocytes, and adipocytes. After induction of neural differentiation, HOFF-derived cells formed spheroidal structures and expressed neural stem cell markers including Nestin, β-tubulin III, and O4. Besides, the oocyte-like structure was observed after prolonged culture of HOFF. In conclusion, cells derived from follicular fluid exhibited stem cell characteristics, which could be useful for regenerative medicine applications and cell-based therapies.
Similar content being viewed by others
References
Kidder GM, Vanderhyden BC. Bidirectional communication between oocytes and follicle cells: ensuring oocyte development competence. Can J Physiol Pharmacol. 2010;88(4):399–413.
Riva F, Omes C, Bassani R, et al. In-vitro culture system for mesenchymal progenitor cells derived from waste human ovarian follicular fluid. Reprod Biomed Online. 2014;29(40):457–69.
Dzafic E, Stimpfel M, Novakovic S, Cerkovnik P, Virant-Klun I. Expression of mesenchymal stem cells-related genes and plasticity of aspirated follicular cells obtained from infertile women. BioMed Res Int. 2014;2014:508216.
Kossowska-Tomaszczuk K, De Geyter C, De Geyter M, et al. The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells. 2009;27(1):210–9.
Dalman A, Totonchi M, Valojerdi MR. Establishment and characterization of human theca stem cells and their differentiation into theca progenitor cells. J Cell Biochem. 2018;119(12):9853–65.
Lai D, Xu M, Zhang Q, et al. Identification and characterization of epithelial cells derived from human ovarian follicular fluid. Stem Cell Res Ther. 2015;6:13.
Khoury R, Abboud MR. Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Rev Hematol. 2011;4(3):343–51.
Lee J, Au WY, Park MJ, et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant. 2008;14(12):1356–64.
El-Chennawi FA, Kamel HA, Mosaad YM, El-Sherbini SM, El-Billey NA. Impact of CD31 mismatched on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling. Hematology. 2006;11(4):227–34.
Tay J, Tinmouth A, Fergusson D, Allan D. Transfusion of red cells in hematopoietic stem cells transplantation (TRIST): study protocol for a randomized controlled trial. Trials. 2011;12(1):207.
Thomson JA, Itskovitz-Eldor S, Shapiro SS, et al. Embryonic stem cells lines derived from human blastocysts. Science. 1998;282(5391):1145–7.
Moschidou D, Mukherjee S, Blundell MP, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012;20(10):1953–67.
Wang F, Wang L, Yao X, Lai D, Guo L. Human amniotic epithelial cells can differentiate into granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure. Stem Cell Res Therapy. 2013;4:124.
Oki Y, Ono H, Motohashi T, Sugiura N, Nobusue H, Kano K. Dedifferentiation follicular granulosa cells derived from pig ovary can transdifferentiate into osteoblasts. Biochem J. 2012;447:239–48.
Phermthai T, Tungprasertpol K, Julavijitphong S, Pokathikorn P, Thongbopit S, Wichitwiengrat S. Successful derivation of xeno-free mesenchymal stem cell lines from endometrium of infertile women. Reprod Biol. 2016;16(4):261–8.
Julavijitphong S, Wichitwiengrat S, Tirawanchai N, Ruangvutilert P, Vantanasiri C, Phermthai T. A xeno-free culture method that enhances Wharton’s jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures. Cytotherapy. 2014;16(5):683–91.
Varras M, Griva T, Kalles V, Akrivis C, Paparisteidis N. Markers of stem cells in human ovarian granulosa cells: is there a clinical significance in ART. J Ovarian Res. 2012;5:36.
Lobb DK, Younglai EV. A simplified method for preparing IVF granulosa cells for culture. J Assist Reprod Genet. 2006;23(2):353–63.
Ferrero H, Delgado-Rosa F, Garcia-Pascual CM, et al. Efficiency and purity provided by the existing methods for the isolation of luteinized granulosa cells: a comparative study. Human Reprod. 2012;29(6):1781–9.
Wu R, Huang C, Wu Q, et al. Exosome secreted by urine-derived stem cells improve stress urinary incontinence by promoting repair of pubococcygeus muscle injury in rats. Stem Cell Res Ther. 2019;10(1):80.
Azedi F, Kazemnejad S, Zarnani AH, Soleimani M, Shojaei A, Arasteh S. Comparative capacity of menstrual blood versus bone marrow derived stem cells in neural differentiation. Mol Biol Rep. 2017;44(1):169–82.
Rungsiwiwut R, Ingrungruanglert P, Numchaisrika P, Virutamasen P, Phermthai T, Pruksananonda K. Human umbilical cord blood-derived serum for culturing the supportive feeder cells of human pluripotent stem cell lines. Stem Cells Int. 2016;2016:4626048.
Virant-Klun I, Kenda-Suster N, Smrkolj S. Small putative NANOG, SOX2 and SSEA-4-positive stem cells resembling very small embryonic-like stem c ells in sections of ovarian tissue in patients with ovarian cancer. J Ovarian Res. 2016;9:12.
Hummitzsch K, Irving-Rodgers HF, Hatzirodos N, et al. A new model of development of the mammalian ovary and follicles. PLoS ONE. 2013;8(2):e55578.
Hsieh M, Zamah AM, Conti M. Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation. Semin Reprod Med. 2009;27(1):52–61.
Hebert TL, Wu X, Yu G, et al. Culture effect of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis. J Tissue Eng Regen Med. 2009;3(7):553–61.
Saipin N, Noophun J, Chumyim P, Rungsiwiwut R. Goat milk: non-invasive source for mammary epithelial cell isolation and in vitro culture. Anat Histol Embryol. 2018;47(3):187–94.
Acknowledgements
The present study was financially supported by the grant from Chulalongkorn University and Srinakharinwirot University (MEDRES 200). The authors are grateful to Dr. Carol Lynn Curchoe for the English editing of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
The protocol of the present study was approved by the Ethical Committee of the Faculty of Medicine, Chulalongkorn University.
Informed consent
The informed consent was obtained from all individual participants included in the present study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rungsiwiwut, R., Numchaisrika, P., Thuwanut, P. et al. Characterization of stem cells from human ovarian follicular fluid; a potential source of autologous stem cell for cell-based therapy. Human Cell 34, 300–309 (2021). https://doi.org/10.1007/s13577-020-00439-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13577-020-00439-2